Eleusis Therapeutics Ltd
Research and experimental development on biotechnology · London
ActiveUnited KingdomIncorporated 2016Private Limited Company
Financial position
Accounts to 2024-12-31 · GBP · Company accounts
Net assets
−£11,075,070
Cash
£69,559
Turnover
—
Profit / loss
—
Current assets
£1,815,066
Creditors < 1 year
—
Equity
−£11,075,070
Average employees
5
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2024-12-31Company | 2023-12-31Company | 2022-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|
| Balance sheet | ||||||||
| Net assets | −£11,075,070 | −£9,135,883 | — | — | — | — | — | — |
| Equity | −£11,075,070 | −£9,135,883 | −£8,263,252 | −£2,390,933 | −£1,059,625 | −£764,146 | −£200,920 | −£117,156 |
| Assets | ||||||||
| Current assets | £1,815,066 | £2,440,232 | £2,352,044 | £166,221 | £191,067 | £354,843 | £485,340 | £0 |
| Cash at bank | £69,559 | £14,970 | £12,267 | £112,360 | £46,187 | £317,653 | £462,543 | £0 |
| Debtors | £1,745,507 | £2,425,262 | £2,339,777 | £53,861 | £144,880 | £37,190 | £22,797 | £0 |
| Liabilities | ||||||||
| Net current assets | −£11,075,070 | −£9,135,883 | −£8,263,252 | −£2,390,933 | −£1,059,625 | −£764,146 | −£200,920 | −£117,156 |
| Assets less current liabilities | −£11,075,070 | −£9,135,883 | −£8,263,252 | −£2,390,933 | −£1,059,625 | −£764,146 | −£200,920 | −£117,156 |
| People & pay | ||||||||
| Average employees | 5 | 7 | 4 | 2 | 1 | 1 | — | — |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesFixed · created 2026-03-11
—
OutstandingShow 1 satisfied / released
All Assets · created 2022-07-27 · satisfied 2026-06-11
—
Satisfied